Sanofi Team Simulates Chemical Compounds Before Clinical Trials

Sanofi is using digital twins to test the efficacy and safety of new chemical compounds before they enter clinical trials.

The company is applying digital twin technology to simulate the behavior of chemical compounds in a virtual environment.

This allows the team to identify potential issues and optimize the compounds before they are tested in humans.

The use of digital twins in drug development is a growing trend in the pharmaceutical industry, as it can reduce the time and cost of bringing new treatments to market.